Presentation is loading. Please wait.

Presentation is loading. Please wait.

IBA Annual Conference September 2016.

Similar presentations


Presentation on theme: "IBA Annual Conference September 2016."— Presentation transcript:

1 IBA Annual Conference September 2016

2 39 $16.8B 22% 205+ 350+ AT A GLANCE… YEARS SINCE INCEPTION COMMITTED
CAPITAL 22% IRR ON $ INVESTED Net to LP over 20 years 205+ IPO EXITS 350+ M&A EXITS

3 NEA CORE STRENGTHS: A WINNING COMBINATION
Scale One of the world’s largest VC firms with a global platform built over four decades, $17B committed capital over 15 funds and 500+ exits Diversification Across sector, stage and geography, NEA is structured for top performance – from our one-fund model to our best-in-class investing practices Network We believe being a good partner leads to great things... that philosophy has helped us cultivate a deeply loyal, global network of entrepreneurs, industry leaders and technologists Team Across tech, healthcare and services, our team collaborates to achieve greatest insight and best outcomes

4 KEY ADVANTAGES: GLOBAL DIVERSIFICATION, SCALE
1 Global Network 1,000+ 5 Investments Over Decades Continents US NEA 13-15 * SEED VC ENTERPRISE CONSUMER BIOPHARMA HEALTH SERVICES MED DVCS. OTHER TECH: 55% MED: 31% *Note: Based on classification at initial investment

5 SOME NEA COMPANIES YOU MAY HAVE HEARD OF…
Ecommerce marketplace Pending M&A M&A | Aug (Walmart) for $3B Seed & Growth | Software & Services Oncology focused targeted therapeutics IPO | June 2012; $4.8B market cap Early | Biopharma Leading enterprise SaaS for human capital management and financials IPO | Oct 2012; $13.9B market cap Growth | Software & Services Monitoring, analytics and risk management for agriculture M&A | Oct 2013 (Monsanto) for $1B Seed | Software & Services Data visualization for business intelligence IPO | May 2013; $4.0B market cap Early | Software & Services Local ecommerce IPO | Nov. 2011; $3.3B Market cap Early & Growth | Consumer Ultrasound based medical device platform M&A | July 2014 (Merz) up to $600M Early | Medical Devices SaaS for event management, web surveys, and marketing IPO | Aug 2013; $1.4B market cap Growth | Software & Services Next-generation online and mobile payments M&A | Oct 2013 (eBay) for $800M Growth | Software & Services SaaS-based customer engagement and energy efficiency company M&A | June 2016 (Oracle) for $623M Early | Energy Tech High frequency spinal cord stimulation to treat chronic pain IPO | Nov 2014; $2.3B market cap Early | Medical Devices Specialty therapeutics targeting gastrointestinal, hepatology M&A | May 2015 (Horizon) for $1.1B Early | Medical Devices affinity enhanced T cell receptor (TCR) engineered T cells to treat hematologic and solid tumor cancers Note: 7 - $1B + market caps – 2 greater than $500M Early stage: Climate, tableau, Epizyme, Xoom, Tesaro, Clovis Mid Stage: Nicira VGE: Braintree, CVENT, Workday Biopharma: Epizyme, Tesaro, Clovis Enteprise/Energy: Climate Corp Payments/Fin Tech: Braintree, XOOM SAAS: CVENT, Workday Systems: Nicira Currently held public company market caps are approximate at 8/8/16. If exited, public market cap is approximate at exit date.

6 TODAY: A REVOLUTION IN HUMAN HEALTH
STUNNING ADVANCES IN ABILITY TO DIAGNOSE, TREAT DISEASE… GENOMIC MEDICINE DISEASE INSIGHT AT MOLECULAR LEVEL NEW MODEL FOR DRUG DEVELOPMENT AS SCIENCE, TECHNOLOGY, AND MACRO TRENDS CONVERGE MAJOR ECOSYSTEM SHIFTS IN DELIVERY OF CARE UNPRECEDENTED PATIENT/CONSUMER ENGAGEMENT HEALTHY M&A, IPO MARKETS FUELING CYCLE

7 FIRST-MOVER IN MEDICAL INNOVATION
Transformative Novel Procedures Personalized Medicine Consumer-Focused Healthcare Allows us to navigate, capitalize on emerging opportunities, regulatory shifts

8 Computing Platform Evolution Drives Tech Innovation Cycles
Mainframe Computing 1960s Personal Computing 1980s Desktop/Internet Computing 1990s Mobile Internet Computing 2000s Wearable/VR Computing NOW TEXT GRAPHICS TOUCH PRESENCE, MOVEMENT, LOCATION

9 Tech Disruption Applies to All Industries

10 WHAT IS VENTURE CAPITAL?
Professional, institutional managers of risk capital for innovation VC funds new ideas that could not be financed with traditional bank financing Long-term equity investment Company’s stock is essentially illiquid and worthless until it matures 3 to 8 years later; may reserve 3-4x the initial investment in “follow-on” capital Follow-on investment provides additional funding for growth; these “rounds” are based on an agreed “valuation” But, unless a company is acquired or goes public, there is little actual value Only one in six companies ever goes public and one in three is acquired Venture capital is more than money Partners become actively engaged, typically taking a board seat With a startup, daily interaction with management is common Limits number of startups in which any one fund can invest

11 SNAPSHOT OF VENTURE CAPITAL INDUSTRY
798 VC firms in existence in 2015, vs. 794 in 2009 $28B in VC capital raised in 2015, vs. $15.4B in 2009 VC investment in 2015 reached $59B, the highest amount since 2000 and the second highest on record Seed and early stage deals represented 36% by $s; software represented 40% and biotech 13% Source: NVCA

12 THE INS & OUTS OF VENTURE INVESTING
Annual VC Dollars Invested Vs.VC-Backed IPOs


Download ppt "IBA Annual Conference September 2016."

Similar presentations


Ads by Google